Pressure BioSciences (PBIO) Stock Chart & Stock Price History $0.0003 0.00 (0.00%) As of 09/19/2025 Add Compare Share Share Chart Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock Pressure BioSciences Stock Price Performance The Pressure BioSciences (PBIO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 98.93%, with a year-to-date return of -91.43%. As of the latest close, Pressure BioSciences traded at $0.00 with a market cap of $13 thousand and volume of 1,742 shares. Five years ago, the stock traded at $1.80, representing a 99.98% decrease over that period. At the time, it had a market cap of $6.95 million and a volume of 2,440 shares. Receive PBIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance0.00%3 Month PerformanceN/AYear-To-Date Performance-91.43%1 Year Performance-98.93%5 Year Performance-99.98% PBIO Stock Chart for Saturday, September, 20, 2025 PBIO Chart by TradingView Pressure BioSciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/19/2025$0.00$0.00$0.00$0.001,742 shs$13,000.0009/18/2025$0.00$0.00$0.00$0.001,742 shs$13,000.0009/16/2025$0.00$0.00$0.00$0.00230 shs$13,000.0009/15/2025$0.00$0.00+50.00%$0.00$0.00230 shs$9,000.0009/12/2025$0.00$0.00+100.00%$0.00$0.0014,988 shs$9,000.0009/11/2025N/A$0.00$0.00$0.00426 shs$4,000.0009/09/2025$0.00$0.00$0.04$0.00200 shs$4,000.0009/08/2025$0.00$0.00$0.04$0.00200 shs$4,000.0009/05/2025N/A$0.00$0.00$0.00100 shs$4,000.0009/02/2025$0.00$0.00$0.00$0.00350 shs$4,000.0009/01/2025$0.00$0.00$0.00$0.00350 shs$4,000.0008/29/2025$0.00$0.00$0.00$0.00350 shs$4,000.0008/28/2025$0.00$0.00$0.00$0.0080,000 shs$4,000.0008/27/2025$0.00$0.00$0.00$0.0080,000 shs$4,000.0008/26/2025$0.00$0.00-50.00%$0.00$0.0080,000 shs$4,000.0008/22/2025$0.00$0.00$0.00$0.003,000 shs$9,000.0008/21/2025N/A$0.00$0.00$0.003,000 shs$9,000.00 Related Companies American Graphite Technologies Stock Chart Arrayit Stock Chart DiaSys Stock Chart Electric & Gas Technology Stock Chart Flexpoint Sensor Systems Stock Chart HTG Molecular Diagnostics Stock Chart Integral Vision Stock Chart OmniLit Acquisition Stock Chart Orthometrix Stock Chart Prenetics Global Stock Chart Receive PBIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PBIO) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pressure BioSciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pressure BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
